CONCLUSION The expanding selection of glucose-lowering agents and the ever-increasing understanding of the impact of these agents on cardiovascular and renal outcomes provides an opportunity for pharmacy professionals to make a notable impact on patient care
Yesabsolutely
The study also showed that ferroptosis is independent of the necroptosis-inhibiting complex in renal tubules, specifically Fas-associated protein with death domain and caspase-8, which are important markers of spontaneous necroptosis
The distribution of fluorescence signal in the liver, kidneys, heart, spleen, lungs, and lower limb joints was observed using an in vivo imaging system on the first and third days, respectively
SELECT showed 20% MACE reduction with semaglutide in patients with established cardiovascular disease, and the secondary cardiovascular benefits (blood pressure, lipids, glucose) may help reduce occupational cardiovascular events
Food and Drug Administration to approve the pills later this year